Curr Opin Mol Ther. 1999 Feb;1(1):104-11.

Immunotherapy-based treatment strategies for malignant mesothelioma.

Source

Louisiana State University Medical Center, Department of Medicine, Section Hematology/Oncology, 1542 Tulane Avenue, New Orleans, LA 70112, USA. pschwa1@isumc.edu

Abstract

Malignant mesothelioma (MM) is a tumor of the pleura with an etiology that has been strongly linked to previous asbestos exposure. It is an almost universally fatal disease, regardless of tumor stage at the time of diagnosis. Current treatment modalities include surgery, chemotherapy and radiation therapy, although in some clinical trials none of these modalities have proven to be superior to no treatment at all. Knowledge of the tumor biology and immunology of this disease is insufficient, although several studies suggest feasibility and success for immunotherapeutic strategies. In this article, we review previous work and describe novel therapeutic approaches utilizing biological response modification for MM.

PMID:: 11249674; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Other Literature Sources

Education

New England Research Institutes Inc.

Medical

Molecular Biology Databases

GANCICLOVIR - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Gene therapy for malignant pleural mesothelioma: present and future. [Oncol Res. 2008]
Review Gene therapy for malignant pleural mesothelioma: present and future.
Tada Y, Takiguchi Y, Hiroshima K, Shimada H, Ueyama T, Nakamura M, Tatsumi K, Kuriyama T, Tagawa M. Oncol Res. 2008; 17(6):239-46.
Review Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana. [J La State Med Soc. 1998]
Review Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger P, Harrison L, Weinacker A, Gaumer R, Theodossiou C, Summer W, Ye P, Marrogi AJ, Ramesh R, Freeman S, et al. J La State Med Soc. 1998 Apr; 150(4):168-74.
Review [Immunotherapy and malignant mesothelioma: clinical perspectives]. [Bull Cancer. 2007]
Review [Immunotherapy and malignant mesothelioma: clinical perspectives].
Grégoire M, Ebstein F. Bull Cancer. 2007 Jan; 94(1):23-31.
Review Gene therapy for malignant pleural mesothelioma. [Hematol Oncol Clin North Am. 1...]
Review Gene therapy for malignant pleural mesothelioma.
Sterman DH, Kaiser LR, Albelda SM. Hematol Oncol Clin North Am. 1998 Jun; 12(3):553-68.
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. [Clin Cancer Res. 2005]
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, et al. Clin Cancer Res. 2005 Oct 15; 11(20):7444-53.

See reviews... See all...

Cited by 1 PubMed Central article

Malignant pleural mesothelioma with long-term tumor disappearance of a local relapse after surgery: a case report. [J Med Case Rep. 2009]
Malignant pleural mesothelioma with long-term tumor disappearance of a local relapse after surgery: a case report.
Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Imamura F. J Med Case Rep. 2009 Mar 27; 3:6800. Epub 2009 Mar 27.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunotherapy-based treatment strategies for malignant mesothelioma.
Immunotherapy-based treatment strategies for malignant mesothelioma.
Curr Opin Mol Ther. 1999 Feb ;1(1):104-11.

PubMed
Familial hyperargininaemia.
Familial hyperargininaemia.
Arch Dis Child. 1975 Jan ;50(1):57-62.

PubMed
Hemodialysis and homelessness: a literature review and a call for research.
Hemodialysis and homelessness: a literature review and a call for research.
Nephrol Nurs J. 2000 Jun ;27(3):305-10.

PubMed
Primary bony tumors of the pediatric spine.
Primary bony tumors of the pediatric spine.
Yale J Biol Med. 2001 Jan-Feb ;74(1):1-8.

PubMed
Release of flexors and intrinsic muscles for finger spasticity in cerebral palsy...
Release of flexors and intrinsic muscles for finger spasticity in cerebral palsy.
Clin Orthop Relat Res. 2001 Mar ;(384):162-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Immunotherapy-based treatment strategies for malignant mesothelioma.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Education

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information